ACE-inibizione, antagonismo recettoriale e terapia combinata in soggetti microalbuminurici con fattori di rischio cardiovascolare. Protocollo dello studio randomizzato multicentrico LIRICO "Long-term Impact of RAS Inhibition on Cardiorenal Outcomes-LIRICO"

Translated title of the contribution: Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes trial

A. Maione, A. Nicolucci, J. C. Craig, G. Tognoni, A. Moschetta, G. Palasciano, G. Pugliese, D. A. Procaccini, L. Gesualdo, F. Pellegrini, G.F.M. Strippoli

Research output: Contribution to journalArticle

Translated title of the contributionAngiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes trial
Original languageItalian
Pages (from-to)446-456
Number of pages11
JournalGiornale Italiano di Nefrologia
Volume24
Issue number5
Publication statusPublished - 2007
Externally publishedYes

Cite this